The Travelers Companies, Inc.
NYSE:TRVInsurance - Property & Casualty
-$1.77 today
- Market cap
- $80.25B
- Beta
- 0.49
- P/E (TTM)
- 8.6
- EPS (TTM)
- $35.33
- Dividend yield
- 1.50%
Volume 1.65M
Average 1.47M
TRV Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
The Travelers Companies, Inc.NYSE: TRV
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How TRV compares with its peers on the latest reported figures
- TRV's LTM Sep 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for TRV, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TRV) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for TRV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.82B | 36.9B | 41.37B | 46.43B | 48.83B |
| Cost of Revenue | 25.34B | 28.37B | 32.44B | 34.03B | 34.49B |
| Gross Profit | 9.48B | 8.53B | 8.93B | 12.4B | 14.34B |
| Gross Margin | 27.2% | 23.1% | 21.6% | 26.7% | 29.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 4.68B | 4.81B | 5.18B | 5.82B | 6.12B |
| Operating Expenses | 5.02B | 5.17B | 5.56B | 6.22B | 6.55B |
| Depreciation & Amortization | 870M | 826M | 722M | 715M | 680M |
| EBITDA | 5.67B | 4.53B | 4.47B | 7.29B | 8.9B |
| EBITDA Margin | 16.3% | 12.3% | 10.8% | 15.7% | 18.2% |
| Operating Income | 4.46B | 3.35B | 3.37B | 6.18B | 7.8B |
| Operating Margin | 12.8% | 9.1% | 8.1% | 13.3% | 16.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 340M | 351M | 376M | 392M | 425M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 4.46B | 3.35B | 3.37B | 6.18B | 7.8B |
| Pre-Tax Margin | 12.8% | 9.1% | 8.1% | 13.3% | 16.0% |
| Income Tax Expense | 796M | 512M | 380M | 1.18B | 1.51B |
| Net Income | 3.66B | 2.84B | 2.99B | 5B | 6.29B |
| Net Margin | 10.5% | 7.7% | 7.2% | 10.8% | 12.9% |
| EPS (Basic) | 14.63 | 11.91 | 12.93 | 21.76 | 27.84 |
| EPS (Diluted) | 14.49 | 11.77 | 12.79 | 21.47 | 27.43 |
| Weighted Avg Shares | 248.5M | 237M | 229.7M | 228M | 224.2M |
| Weighted Avg Shares (Diluted) | 250.8M | 239.7M | 232.2M | 231.1M | 227.6M |
The Travelers Companies, Inc.
NYSE:TRV
Intrinsic Alpha fair value
Locked
Current Price
$391.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.